Emilie P Belley-Cote

Jun 14, 2024 | onlinecjc.ca | Sean van Diepen |Patricia Alfaro |Michael Goldfarb |Adriana Luk |Rebecca Mathew |Maude Peretz-Larochelle | +7 more

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Apr 8, 2024 | onlinecjc.ca | Sean van Diepen |Patricia Alfaro |Michael Goldfarb |Adriana Luk |Rebecca Mathew |Erin Rayner-Hartley | +7 more

Abstract Survival to hospital discharge among patients with out-of-hospital cardiac arrest (OHCA) is low and important regional differences in treatment practices and survival have been described. Since the 2017 publication of the Canadian Cardiovascular Society’s position statement on OHCA care, multiple randomized controlled trials have helped to better define optimal post cardiac arrest care.

Oct 28, 2023 | onlinecjc.ca | Kevin Bainey |Guillaume Marquis-Gravel |Emilie P Belley-Cote |Ricky Turgeon

•Current practice emphasizes consideration for maintenance of chronic ASA therapy before elective coronary angiography. For elective coronary angiography with possibility of PCI, if a patient is not on chronic ASA therapy, a loading dose of ASA is usually administered orally before the procedure. •For planned elective PCI, current practice emphasizes consideration for pre-treatment with DAPT at least 2 hours before PCI.

Oct 28, 2023 | onlinecjc.ca | Kevin Bainey |Guillaume Marquis-Gravel |Emilie P Belley-Cote |Ricky Turgeon

AbstractAntiplatelet therapy (APT) is the foundation of treatment and prevention of atherothrombotic events in patients with atherosclerotic cardiovascular disease. Selecting the optimal APT strategies to reduce major adverse cardiovascular events, while balancing bleeding risk, requires ongoing review of clinical trials.

Oct 12, 2023 | jamanetwork.com | Deborah M. Siegal |Emilie P Belley-Cote |Stephen Hill |Université de Sherbrooke

Key PointsQuestion  Does transitioning from standard-volume to small-volume blood collection tubes for laboratory testing in intensive care units (ICUs) reduce red blood cell (RBC) transfusion?